Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Half-side comparative nasal bioavailability study of MP29-02 vs fluticasone propionate
2015-002865-40Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Nov 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of fluticasone propionate in ear (not a disease), nasal congestion, chronic rhinosinusitis (CRS) and 1 more, sponsored by Ghent University Hospital. Started Nov 2015; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
ear (not a disease)nasal congestionchronic rhinosinusitis (CRS)deviated nasal septum (DNS)
Beyond the preview
Go deeper on 2015-002865-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002865-40.